Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with national and international re
Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with national and international research centers, have identified a key immune cell subtype involved in the development of atherosclerosis. In a study published in Circulation Research, the team tested an experimental therapy in animal models based on immunosuppressive nanoparticles and demonstrated that it can slow disease progression. Atherosclerosis is a chronic cardiovascular disease that affects millions of people worldwide. The disease is marked by the accumulation of cholesterol—especially low-density lipoprotein (LDL)—in the arterial walls, leading to plaque formation that restricts blood flow.
Continue Reading.


















